111 related articles for article (PubMed ID: 2108046)
1. Lymphokines and bacteria, that induce tumoricidal activity, trigger a different secretory response in macrophages.
Keller R; Keist R; Frei K
Eur J Immunol; 1990 Mar; 20(3):695-8. PubMed ID: 2108046
[TBL] [Abstract][Full Text] [Related]
2. Induction of interleukin 1 secretion and of tumoricidal activity in macrophages are not closely related phenomena.
Keller R; Keist R
Eur J Immunol; 1987 Nov; 17(11):1665-8. PubMed ID: 3119353
[TBL] [Abstract][Full Text] [Related]
3. Induction, maintenance, and reinduction of tumoricidal activity in bone marrow-derived mononuclear phagocytes by Corynebacterium parvum. Evidence for the involvement of a T cell- and interferon-gamma-independent pathway of macrophage activation.
Keller R; Keist R; Van der Meide PH; Groscurth P; Aguet M; Leist TP
J Immunol; 1987 Apr; 138(7):2366-71. PubMed ID: 3104463
[TBL] [Abstract][Full Text] [Related]
4. Modulation of major histocompatibility complex (MHC) expression by interferons and microbial agents. Independent regulation of MHC class II expression and induction of tumoricidal activity in bone marrow-derived mononuclear phagocytes.
Keller R; Joller P; Keist R; Binz H; van der Meide PH
Scand J Immunol; 1988 Jul; 28(1):113-21. PubMed ID: 2456605
[TBL] [Abstract][Full Text] [Related]
5. Abilities of activated macrophages to manifest tumoricidal activity and to generate reactive nitrogen intermediates: a comparative study in vitro and ex vivo.
Keller R; Keist R
Biochem Biophys Res Commun; 1989 Nov; 164(3):968-73. PubMed ID: 2511844
[TBL] [Abstract][Full Text] [Related]
6. Discrepancy in the abilities of lymphokines and bacteria to mediate tumor protection in vivo and/or tumoricidal activity by macrophages in vitro.
Keller R; Keist R; Schwendener RA
Int J Cancer; 1989 Sep; 44(3):512-7. PubMed ID: 2506137
[TBL] [Abstract][Full Text] [Related]
7. Modulation of tumoricidal activity, induced in bone-marrow-derived mononuclear phagocytes by interferon gamma or Corynebacterium parvum, by interferon beta, tumor necrosis factor, prostaglandin E2, and transforming growth factor beta.
Keller R; Keist R; van der Meide PH
Int J Cancer; 1991 Nov; 49(5):796-800. PubMed ID: 1937965
[TBL] [Abstract][Full Text] [Related]
8. B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens.
Crawford RM; Finbloom DS; Ohara J; Paul WE; Meltzer MS
J Immunol; 1987 Jul; 139(1):135-41. PubMed ID: 3108395
[TBL] [Abstract][Full Text] [Related]
9. Rapid decay of tumoricidal activity and loss of responsiveness to lymphokines in inflammatory macrophages.
Poste G; Kirsh R
Cancer Res; 1979 Jul; 39(7 Pt 1):2582-90. PubMed ID: 87267
[TBL] [Abstract][Full Text] [Related]
10. Macrophage activation by interferon: dissociation between tumoricidal capacity and suppressive activity.
Boraschi D; Soldateschi D; Tagliabue A
Eur J Immunol; 1982 Apr; 12(4):320-6. PubMed ID: 6178603
[TBL] [Abstract][Full Text] [Related]
11. The tumoricidal properties of inflammatory tissue macrophages and multinucleate giant cells.
Poste G
Am J Pathol; 1979 Aug; 96(2):595-610. PubMed ID: 382866
[TBL] [Abstract][Full Text] [Related]
12. Macrophage response to viruses, protozoa, and fungi: secretory and cellular activities induced in resting unprimed bone marrow-derived mononuclear phagocytes.
Keller R; Gehri R; Keist R
Cell Immunol; 1994 Dec; 159(2):323-30. PubMed ID: 7994764
[TBL] [Abstract][Full Text] [Related]
13. Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-beta 1.
Nelson BJ; Ralph P; Green SJ; Nacy CA
J Immunol; 1991 Mar; 146(6):1849-57. PubMed ID: 1900875
[TBL] [Abstract][Full Text] [Related]
14. Interferon-induced enhancement of macrophage-mediated tumor cytolysis and its difference from activation by lymphokines.
Boraschi D; Tagliabue A
Eur J Immunol; 1981 Feb; 11(2):110-4. PubMed ID: 6163639
[TBL] [Abstract][Full Text] [Related]
15. Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.
Hori K; Mihich E; Ehrke MJ
Cancer Res; 1989 May; 49(10):2606-14. PubMed ID: 2496917
[TBL] [Abstract][Full Text] [Related]
16. Defective tumoricidal capacity of macrophages from P/J mice: tumoricidal defect involves abnormalities in lymphokine-derived activation stimuli and in mononuclear phagocyte responsiveness.
Boraschi D; Meltzer MS
J Immunol; 1980 Aug; 125(2):777-82. PubMed ID: 6993563
[No Abstract] [Full Text] [Related]
17. [Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice and rats].
Ogura T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):689-96. PubMed ID: 3083782
[TBL] [Abstract][Full Text] [Related]
18. Effect of recombinant human tumor necrosis factor on the induction of murine macrophage tumoricidal activity.
Hori K; Ehrke MJ; Mace K; Maccubbin D; Doyle MJ; Otsuka Y; Mihich E
Cancer Res; 1987 Jun; 47(11):2793-8. PubMed ID: 2882835
[TBL] [Abstract][Full Text] [Related]
19. Evidence for effects of interleukin 4 (B cell stimulatory factor 1) on macrophages: enhancement of antigen presenting ability of bone marrow-derived macrophages.
Zlotnik A; Fischer M; Roehm N; Zipori D
J Immunol; 1987 Jun; 138(12):4275-9. PubMed ID: 3495588
[TBL] [Abstract][Full Text] [Related]
20. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
Howard AD; Erickson KL
Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
